Spacio-temporal determination of polypeptide structure
AssigneePeptone, LTD.
InventorsOliver Dutton, Carlo Fisicaro, Matthew Michael Heberling, Louie Derek Henderson, Istvan Redl, Kamil Tamiola
Life of this patent
Estimating the term…
Abstract
Disclosed herein are methods of in silico generation of polypeptide structures using time-based data generated from molecular dynamics simulations. Also disclosed herein are methods of predicting an epitope or binding surface of a polypeptide using in silico methods. Also disclosed herein are compositions containing polypeptide therapeutics designed to bind to a predicted epitope structure of a polypeptide, as well as methods of treating a subject by administering to the subject compositions containing the same.
Claims17
A method of analyzing and ranking epitope structures of a target polypeptide for targeting by a therapeutic, the method comprising:
- a. providing a polypeptide sequence of a target polypeptide;
- b. computing a protein homology model from the polypeptide sequence;
- c. applying a molecular dynamics (MD) simulation to the protein homology model to obtain a 3D protein ensemble of the target polypeptide;
- d. constructing a graph network by assigning individual alpha carbon atoms in the 3D protein ensemble as nodes and interactions between neighboring alpha carbon backbone atoms as graph edges;
- e. identifying a plurality of epitope structures in the polypeptide sequence using a model that is trained to identify epitope structures from the graph network;
- f. calculating index scores for the plurality of epitope structures in the polypeptide sequence, wherein the index scores are calculated based on at least two of:
- a structural prominence parameter, a disorder parameter, or a conservation parameter of the epitope, wherein:
- i. the structural prominence parameter is derived from the 3D protein ensemble;
- ii. the disorder parameter is determined by a root mean square fluctuation of an alpha carbon in a backbone of the target polypeptide in the 3D protein ensemble;
- iii. the conservation parameter is calculated based on conservation of at least two amino acid residues in a multiple sequence alignment comprising the polypeptide sequence of the target polypeptide;
- and
- iv. the index scores are proportional to the structural prominence parameter and the conservation parameter, and are inversely proportional to the disorder parameter;
- and
- g. ranking an epitope structure among the plurality of epitope structures having the highest index scores in a ranking of index scores, thereby generating a ranked range of epitope structures of the target polypeptide available for subsequent selection for targeting with the therapeutic;
- h. selecting the epitope structure with the highest ranked index score from the ranked range of epitope structures of the target polypeptide for generating a paratope structure;
- i. generating the paratope structure for the therapeutic that is predicted to bind to the epitope structure;
- wherein the therapeutic comprises the paratope structure;
- and
- j. making the therapeutic by a process that comprises chemical synthesis or expression in a host cell.
Dependencies are inferred from the claim text.